![]() |
市场调查报告书
商品编码
1700089
2032 年医疗美容设备市场预测:按产品类型、应用、最终用户和地区进行的全球分析Medical Aesthetic Devices Market Forecasts to 2032 - Global Analysis By Product Type, Application, End User and By Geography |
根据 Stratistics MRC 的数据,全球医疗美容设备市场预计在 2025 年达到 177 亿美元,到 2032 年将达到 368 亿美元,预测期内的复合年增长率为 11%。
医疗美容设备是用于改变体形、治疗皮肤问题和改善外观等美容手术的先进设备。这些设备包括射频设备、基于能量的设备、雷射系统、微晶换肤设备等等。它们用于疤痕治疗、塑身、除毛、活肤等。这些方法广泛应用于医院、医疗水疗中心和皮肤病诊所,可确保美容手术的微创性和高成功率。
《国际医学资讯学期刊》发表的一项研究显示,近 60% 的台湾劳工阶级每年在整形外科和显微手术上花费 2,300美国至 6,700 美元。
人口老化加剧
全球老龄人口的不断增加是医疗美容设备市场的主要推动力。越来越多的老年人寻求治疗来解决与老龄化相关的问题,如皱纹、体积减少和皮肤鬆弛。根据世界卫生组织预测,到 2050 年,60 岁以上人口数量将增加一倍,这将刺激抗衰老治疗的需求。此外,包括雷射治疗和真皮填充剂在内的微创技术的进步满足了这一人群对快速恢復和自然效果的偏好。这些人口结构的变化确保了持续的需求。
医疗费用高昂
雷射系统和基于能量的设备等先进技术需要大量的前期投资,这限制了中端诊所和患者的使用。此外,维护成本和选择性美容手术缺乏保险覆盖也加剧了财务挑战。例如,飞梭雷射治疗每次治疗的费用超过 1,000 美元,这让注重价格的消费者望而却步。这种经济负担限制了市场渗透,尤其是在可支配收入较低的地区。
非侵入性手术的扩展
肉毒桿菌注射、超音波治疗和冷冻溶脂等非侵入性和微创手术的日益普及代表着巨大的成长机会。这些疗程吸引了那些寻求美容但又不想承受手术风险和停机时间的消费者。此外,人工智慧设备和可携式系统等技术创新正在扩大可访问性。那些投资于研发轻鬆高效解决方案的公司正在获得关注,尤其是在年轻人群中。全球范围内向「午餐治疗」和预防性美容治疗的转变进一步放大了这一趋势,为市场参与者创造了有利可图的管道。
负面声誉和虚假讯息
有关失败程序的负面宣传和社交媒体上的错误讯息威胁着市场的成长。由于不合格的医生和不合格的设备而导致的併发症的严重案例损害了消费者的信心。此外,经过编辑的社群媒体内容所引发的不切实际的期望会导致挫折感并疏远潜在客户。监管机构已加强监管,但全球标准仍不一致。
2020年,疫情暂时扰乱了医美设备市场。供应链瓶颈导致设备生产延迟,可支配收入下降抑制了需求。然而,疫情过后,在强劲需求和医疗旅游復苏的推动下,经济出现了强劲復苏。此外, LED 面膜和微电流工具等家用美容设备的兴起在停工期间也广受欢迎,形成了混合需求模式。
预计预测期内能源设备领域将实现最大幅度成长。
由于对雷射、超音波和射频美容疗程的需求不断增长,预计预测期内基于能量的设备部分将占据最大的市场占有率。这些设备为紧緻皮肤、减少脂肪、除毛和减少皱纹提供了有效的解决方案,停机时间最短。此外,持续的技术进步正在提高治疗效率和患者的治疗效果,从而导致诊所和医疗水疗中心越来越多地采用该技术。此外,消费者对非侵入性美容手术的认识和接受度不断提高,进一步增强了该领域的主导地位。
预计预测期内家用领域将以最高的复合年增长率成长。
由于消费者对便利且经济实惠的美容护理的偏好日益增强,预计家用美容领域将在预测期内实现最高增长率。用于活肤、除毛和抗衰老疗法的便携式和易于使用的设备的出现正在推动市场扩张。此外,新冠疫情加速了人们向居家美容解决方案的转变,进一步增加了需求。此外,设备安全性、有效性以及与行动应用程式的连接性的进步正在改善用户体验,促进家用美容设备的快速普及。
由于消费者在整容手术上的支出较高且医疗保健基础设施完善,预计北美将在预测期内占据最大的市场占有率。微创和非侵入性治疗的日益接受度以及主要市场参与者的存在也在加强区域优势。此外,技术进步和频繁的产品推出也促进了市场的扩张。此外,人们的意识不断增强以及社交媒体的影响力正在推动医疗美容设备的普及,从而巩固了该公司作为北美行业领先者的地位。
由于可支配收入增加、美容意识增强以及医疗旅游业扩大,预计亚太地区将在预测期内出现最高的复合年增长率。由于中等收入阶层的扩大和美容治疗需求的增加,中国、印度和韩国等国家正在经历显着的成长。此外,美容技术的进步和可负担的治疗费用正在吸引更大的消费者群体。此外,熟练劳动力的存在和政府的支持政策进一步加速了该地区对医疗美容设备的采用。
According to Stratistics MRC, the Global Medical Aesthetic Devices Market is accounted for $17.7 billion in 2025 and is expected to reach $36.8 billion by 2032 growing at a CAGR of 11% during the forecast period. Medical aesthetic devices are advanced instruments used in cosmetic procedures to alter body shapes, treat skin problems, and enhance looks. These gadgets include radiofrequency equipment, energy-based gadgets, laser systems, and microdermabrasion instruments. They are applied to scar therapy, body shaping, hair removal, and skin rejuvenation. These methods, which are widely used in hospitals, medical spas, and dermatology clinics, guarantee minimally invasive and successful aesthetic procedures.
According to a study published in the International Journal of Medical Informatics, nearly 60% of Taiwan's working class spent between US $2300 to US $6700 on plastic surgery and microsurgery each year.
Increasing aging population
The global rise in the aging population is a key driver for the medical aesthetic devices market, as older individuals increasingly seek treatments to address age-related concerns such as wrinkles, volume loss, and skin laxity. According to the WHO, the population aged 60+ is projected to double by 2050, fueling demand for anti-aging procedures. Furthermore, advancements in minimally invasive technologies, including laser therapies and dermal fillers, cater to this demographic's preference for quick recovery and natural results. This demographic shift ensures sustained demand.
High cost of treatments
Advanced technologies like laser systems and energy-based devices require substantial upfront investments, limiting accessibility for mid-tier clinics and patients. Additionally, maintenance expenses and the lack of insurance coverage for elective aesthetic treatments exacerbate affordability challenges. For example, a single session of fractional laser therapy can cost upwards of $1,000, deterring price-sensitive consumers. This financial burden restricts market penetration, especially in regions with lower disposable incomes.
Expanding non-invasive procedures
The growing popularity of non-invasive and minimally invasive procedures, such as Botox, ultrasound therapy, and cryolipolysis, presents a major growth opportunity. These treatments appeal to consumers seeking aesthetic enhancements without surgical risks or downtime. Moreover, technological innovations like AI-powered devices and portable systems are broadening accessibility. Companies investing in R&D for pain-free, efficient solutions are gaining traction, particularly among younger demographics. The global shift toward "lunchtime procedures" and preventive aesthetics further amplifies this trend, creating a lucrative pipeline for market players.
Negative publicity and misinformation
Negative publicity surrounding botched procedures and misinformation on social media platforms threatens market growth. High-profile cases of complications from unqualified practitioners or substandard devices erode consumer trust. Additionally, unrealistic expectations fueled by edited social media content lead to dissatisfaction, deterring potential clients. Regulatory bodies are intensifying scrutiny, but inconsistent standards globally persist.
The pandemic temporarily disrupted the medical aesthetics market in 2020, as lockdowns forced clinics to close and patients deferred elective procedures. Supply chain bottlenecks delayed device manufacturing, while reduced disposable incomes lowered demand. However, the post-pandemic period saw a robust rebound, driven by pent-up demand and the resurgence of medical tourism. Additionally, the rise of at-home aesthetic devices, such as LED masks and microcurrent tools, gained traction during lockdowns, creating a hybrid demand model.
The energy-based devices segment is expected to be the largest during the forecast period
The energy-based devices segment is expected to account for the largest market share during the forecast period, driven by rising demand for laser, ultrasound, and radiofrequency-based aesthetic treatments. These devices offer effective solutions for skin tightening, fat reduction, hair removal, and wrinkle reduction with minimal downtime. Additionally, continuous technological advancements improve treatment efficiency and patient outcomes, increasing adoption among clinics and medspas. Moreover, growing consumer awareness and acceptance of non-invasive aesthetic procedures further contribute to the segment's dominance.
The home use segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the home use segment is predicted to witness the highest growth rate, driven by increasing consumer preference for convenient and cost-effective aesthetic treatments. The availability of portable and easy-to-use devices for skin rejuvenation, hair removal, and anti-aging treatments has fueled market expansion. Additionally, the Covid-19 pandemic accelerated the shift toward at-home beauty solutions, further increasing demand. Moreover, advancements in device safety, efficacy, and connectivity with mobile applications enhance user experience, contributing to the rapid adoption of home-use aesthetic devices
During the forecast period, the North America region is expected to hold the largest market share, attributed to high consumer spending on aesthetic procedures and a well-established healthcare infrastructure. The growing acceptance of minimally invasive and non-invasive treatments, along with the presence of key market players, further strengthens the region's dominance. Additionally, technological advancements and frequent product launches contribute to market expansion. Moreover, increasing awareness and social media influence encourage a higher adoption rate of medical aesthetic devices, reinforcing North America's leadership position in the industry.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by rising disposable incomes, increasing beauty consciousness, and growing medical tourism. Countries such as China, India, and South Korea are witnessing significant growth due to an expanding middle-class population and increasing demand for aesthetic treatments. Additionally, advancements in aesthetic technologies and affordability of treatments attract a larger consumer base. Moreover, the presence of a skilled workforce and supportive government policies further accelerate the adoption of medical aesthetic devices in the region.
Key players in the market
Some of the key players in Medical Aesthetic Devices Market include AbbVie Inc., Alma Lasers, Bausch Health Companies Inc., Cynosure, Johnson & Johnson, Cutera Inc., El.En. S.p.A., Lumenis Ltd., Sciton Inc., Candela Corporation, Venus Concept, Merz Pharma, Galderma S.A., Hologic Inc., Boston Scientific Corporation, Stryker Corp, Syneron Medical Ltd. and InMode Ltd.
In February 2025, Lumenis Be. Ltd. announced the launch of OptiLIFT, a new, proprietary Dynamic Muscle Stimulation technology (DMSt) for toning facial muscles to address lower lid laxity and impaired blinking without the need for surgery. OptiLIFT is also the inventor of OptiLIGHT, an intense pulsed light (IPL) device granted authorization by the FDA for dry eye management.
In April 2024, Sciton Inc., a pioneer in medical and aesthetic laser and light source technologies, proudly unveiled BBL (R) HEROic(TM) this weekend at the inaugural Skin CEO event in Austin, TX. This latest addition to the award-winning BBL product line represents a significant leap forward, incorporating Intelligent Control(TM) (IC(TM)), and the unique Skin Positioning System(TM) (SPS(TM)) for unmatched patient outcomes.
In March 2024, AbbVie and Allergan Aesthetics, an AbbVie company announced they will present 29 abstracts, including three late-breaking presentations, during the 2024 American Academy of Dermatology (AAD) Annual Meeting, March 8-12, in San Diego, California. The presented data across AbbVie and Allergan Aesthetics' extensive portfolios reinforce the companies' ongoing commitment to developing transformative medical dermatology and aesthetic treatments to advance and redefine the standard of care for patients.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.